Pharmaceutical Transportation Services Market Size, Share & Trends Analysis Report By Type (Biopharmaceuticals, Pharmaceuticals), By Service (Air Freight, Sea Freight, Overland), By Supply Chain, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Pharmaceutical Transportation Services Market Growth & Trends
The global pharmaceutical transportation services market size is expected to reach USD 124.81 billion by 2030, registering a CAGR of 7.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to increasing demand for temperature sensitive drugs, expansion of pharmaceutical supply chain, and implementation of stringent guideline.
The growing use of biologics, vaccines, and cell and gene therapies has positively impacted the pharmaceutical transportation services market. Unlike conventional small-molecule drugs, biologics are highly sensitive to temperature variations and physical handling, requiring strict cold chain logistics to maintain product integrity. This demand has led to the proliferation of specialized refrigerated vehicles, cold storage warehouses, and packaging solutions that ensure uninterrupted temperature control throughout the shipping process. The rollout of large-scale vaccination programs, including COVID-19 vaccine distribution, demonstrated the critical importance of temperature-controlled transport and accelerated investment in cold chain infrastructure.
Furthermore, the pharmaceutical companies are increasingly outsourcing manufacturing and distribution activities to contract development and manufacturing organizations (CDMOs) and contract logistics partners, further expanding global supply chains. These complex networks span across regions, creating a need for reliable, secure, and timely transportation services that meet both international and local regulatory standards. Drug components may be produced in one country, assembled in another, and distributed across multiple markets, necessitating synchronized logistics planning. As production decentralizes, the reliance on third-party logistics providers (3PLs) with expertise in navigating customs, documentation, and multi-modal transport has increased. Furthermore, emerging markets in Asia-Pacific, Latin America, and Eastern Europe have become important hubs for both manufacturing and consumption, increasing the frequency and volume of international pharmaceutical shipments.
Furthermore, several key competitors in the market, such as DHL, UPS Healthcare, FedEx Express, and Kuehne+Nagel, are actively expanding capabilities through strategic investments, partnerships, and technology adoption to gain market share. The rising demand for cold chain logistics has led these players to enhance their infrastructure and service offerings. For instance, in April 2025, DHL invested USD 2.27 billion in health logistics to strengthen its life sciences and healthcare logistics, aligning with its "Strategy 2030." Half of the investment targets the U.S., with the rest split between Asia Pacific and EMEA, expanding global infrastructure. This move reinforces DHL's role as a key competitor in providing integrated, patient-focused pharmaceutical transportation solutions.
Pharmaceutical Transportation Services Market Report Highlights
CEVA Logistics
Cencora Corporation (ICS)
DB SCHENKER
Kuehne+Nagel
Kerry Logistics Network Limited
Cardinal Health
McKesson Corporation
EVERSANA
Thermo Fisher Scientific
Knipper Health
FedEx
DHL
Pharmaceutical Transportation Services Market Growth & Trends
The global pharmaceutical transportation services market size is expected to reach USD 124.81 billion by 2030, registering a CAGR of 7.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to increasing demand for temperature sensitive drugs, expansion of pharmaceutical supply chain, and implementation of stringent guideline.
The growing use of biologics, vaccines, and cell and gene therapies has positively impacted the pharmaceutical transportation services market. Unlike conventional small-molecule drugs, biologics are highly sensitive to temperature variations and physical handling, requiring strict cold chain logistics to maintain product integrity. This demand has led to the proliferation of specialized refrigerated vehicles, cold storage warehouses, and packaging solutions that ensure uninterrupted temperature control throughout the shipping process. The rollout of large-scale vaccination programs, including COVID-19 vaccine distribution, demonstrated the critical importance of temperature-controlled transport and accelerated investment in cold chain infrastructure.
Furthermore, the pharmaceutical companies are increasingly outsourcing manufacturing and distribution activities to contract development and manufacturing organizations (CDMOs) and contract logistics partners, further expanding global supply chains. These complex networks span across regions, creating a need for reliable, secure, and timely transportation services that meet both international and local regulatory standards. Drug components may be produced in one country, assembled in another, and distributed across multiple markets, necessitating synchronized logistics planning. As production decentralizes, the reliance on third-party logistics providers (3PLs) with expertise in navigating customs, documentation, and multi-modal transport has increased. Furthermore, emerging markets in Asia-Pacific, Latin America, and Eastern Europe have become important hubs for both manufacturing and consumption, increasing the frequency and volume of international pharmaceutical shipments.
Furthermore, several key competitors in the market, such as DHL, UPS Healthcare, FedEx Express, and Kuehne+Nagel, are actively expanding capabilities through strategic investments, partnerships, and technology adoption to gain market share. The rising demand for cold chain logistics has led these players to enhance their infrastructure and service offerings. For instance, in April 2025, DHL invested USD 2.27 billion in health logistics to strengthen its life sciences and healthcare logistics, aligning with its "Strategy 2030." Half of the investment targets the U.S., with the rest split between Asia Pacific and EMEA, expanding global infrastructure. This move reinforces DHL's role as a key competitor in providing integrated, patient-focused pharmaceutical transportation solutions.
Pharmaceutical Transportation Services Market Report Highlights
- Based on type, the biopharmaceuticals segment dominated the market in 2024. The growth of this segment is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, gene therapies, and personalized medications.
- Based on the services, the air freight segment dominated the market in 2024. The growth of this segment is largely attributed to the increasing demand for rapid delivery of high-value, time-sensitive, and temperature-controlled pharmaceutical products.
- Based on the supply chain, the non-cold chain logistics segment dominated the market in 2024. The segment’s growth is due to the rising demand for medical devices, over the counter (OTC) drugs, and general pharmaceutical distribution.
CEVA Logistics
Cencora Corporation (ICS)
DB SCHENKER
Kuehne+Nagel
Kerry Logistics Network Limited
Cardinal Health
McKesson Corporation
EVERSANA
Thermo Fisher Scientific
Knipper Health
FedEx
DHL
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Purchased Database
1.3.3. GVR’s Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.4. Information or Data Analysis
1.4.1. Information Analysis
1.4.2. Market Formulation & Data Visualization
1.4.3. Data Validation & Publishing
1.5. Model Details
1.5.1. Commodity Flow Analysis (Model 1)
1.5.2. Top Down Market Estimation (Model 2)
1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
1.5.4. Multivariate Analysis (Model 4)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Demand for Biopharmaceuticals and Specialty Drugs
3.2.1.2. Expansion of Global Pharmaceutical Supply Chain
3.2.1.3. Stringent Regulatory Requirements and Quality Assurance Standards
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Cold Chain Infrastructure and Maintenance
3.2.2.2. Complex Regulatory and Customs Compliance Across Regions
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Industry Market Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
3.5.3. COVID-19 Impact Analysis
CHAPTER 4. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Pharmaceutical Transportation Services Market Type Movement Analysis
4.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Biopharmaceuticals
4.4.1. Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. Vaccines
4.4.2.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Biosimilars
4.4.3.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. Plasma Derived Products
4.4.4.1. Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Pharmaceuticals
4.5.1. Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: SERVICES ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Pharmaceutical Transportation Services Market Services Movement Analysis
5.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
5.4. Air Freight
5.4.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Sea Freight
5.5.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Overland
5.6.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: SUPPLY CHAIN ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Pharmaceutical Transportation Services Market Supply Chain Movement Analysis
6.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Supply Chain, 2018 to 2030 (USD Million)
6.4. Cold Chain Logistics
6.4.1. Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Non-cold Chain Logistics
6.5.1. Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
7.4. North America
7.4.1. North America Market Estimates and Forecasts 2018 to 2030, (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory scenario
7.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory scenario
7.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory scenario
7.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory scenario
7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory scenario
7.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory scenario
7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory scenario
7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory scenario
7.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory scenario
7.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Norway
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory scenario
7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Sweden
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Regulatory scenario
7.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory scenario
7.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory scenario
7.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory scenario
7.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory scenario
7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory scenario
7.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory scenario
7.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory scenario
7.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory scenario
7.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory scenario
7.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory scenario
7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory scenario
7.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory scenario
7.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Competition Categorization
8.2. Company Market Share/Assessment Analysis, 2024
8.3. Company Profiles
8.3.1. CEVA Logistics
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cencora Corporation (ICS)
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. DB SCHENKER
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Kuehne+Nagel
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Kerry Logistics Network Limited
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Cardinal Health
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. FedEx
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. McKesson Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. DHL
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. EVERSANA
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Service benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Thermo Fisher Scientific
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Service benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Knipper Health
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Service benchmarking
8.3.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Purchased Database
1.3.3. GVR’s Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.4. Information or Data Analysis
1.4.1. Information Analysis
1.4.2. Market Formulation & Data Visualization
1.4.3. Data Validation & Publishing
1.5. Model Details
1.5.1. Commodity Flow Analysis (Model 1)
1.5.2. Top Down Market Estimation (Model 2)
1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
1.5.4. Multivariate Analysis (Model 4)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Demand for Biopharmaceuticals and Specialty Drugs
3.2.1.2. Expansion of Global Pharmaceutical Supply Chain
3.2.1.3. Stringent Regulatory Requirements and Quality Assurance Standards
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Cold Chain Infrastructure and Maintenance
3.2.2.2. Complex Regulatory and Customs Compliance Across Regions
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Industry Market Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
3.5.3. COVID-19 Impact Analysis
CHAPTER 4. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Pharmaceutical Transportation Services Market Type Movement Analysis
4.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Biopharmaceuticals
4.4.1. Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. Vaccines
4.4.2.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Biosimilars
4.4.3.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. Plasma Derived Products
4.4.4.1. Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Pharmaceuticals
4.5.1. Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: SERVICES ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Pharmaceutical Transportation Services Market Services Movement Analysis
5.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
5.4. Air Freight
5.4.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Sea Freight
5.5.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Overland
5.6.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: SUPPLY CHAIN ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Pharmaceutical Transportation Services Market Supply Chain Movement Analysis
6.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Supply Chain, 2018 to 2030 (USD Million)
6.4. Cold Chain Logistics
6.4.1. Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Non-cold Chain Logistics
6.5.1. Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. PHARMACEUTICAL TRANSPORTATION SERVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
7.4. North America
7.4.1. North America Market Estimates and Forecasts 2018 to 2030, (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory scenario
7.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory scenario
7.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Regulatory scenario
7.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory scenario
7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory scenario
7.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory scenario
7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory scenario
7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory scenario
7.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory scenario
7.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.8. Norway
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory scenario
7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
7.5.9. Sweden
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Regulatory scenario
7.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory scenario
7.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory scenario
7.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory scenario
7.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory scenario
7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory scenario
7.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory scenario
7.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory scenario
7.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory scenario
7.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory scenario
7.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory scenario
7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory scenario
7.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Regulatory scenario
7.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Competition Categorization
8.2. Company Market Share/Assessment Analysis, 2024
8.3. Company Profiles
8.3.1. CEVA Logistics
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Service benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Cencora Corporation (ICS)
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Service benchmarking
8.3.2.4. Strategic initiatives
8.3.3. DB SCHENKER
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Service benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Kuehne+Nagel
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Service benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Kerry Logistics Network Limited
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Service benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Cardinal Health
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Service benchmarking
8.3.6.4. Strategic initiatives
8.3.7. FedEx
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Service benchmarking
8.3.7.4. Strategic initiatives
8.3.8. McKesson Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Service benchmarking
8.3.8.4. Strategic initiatives
8.3.9. DHL
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Service benchmarking
8.3.9.4. Strategic initiatives
8.3.10. EVERSANA
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Service benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Thermo Fisher Scientific
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Service benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Knipper Health
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Service benchmarking
8.3.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 5 Global pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 6 Global pharmaceutical transportation services Market, by Region, 2018 - 2030 (USD Million)
Table 7 North America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 8 North America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 9 North America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 10 U.S. pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 11 U.S. pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 12 U.S. pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 13 Canada pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 14 Canada pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 15 Canada pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 16 Mexico pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 17 Mexico pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 18 Mexico pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 19 Europe pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 21 Europe pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 22 Europe pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 23 Germany pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 24 Germany pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 25 Germany pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 26 UK pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 27 UK pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 28 UK pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 29 France pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 30 France pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 31 France pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 32 Italy pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 33 Italy pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 34 Italy pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 35 Spain pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 36 Spain pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 37 Spain pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 38 Denmark pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 39 Denmark pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 40 Denmark pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 41 Norway pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 42 Norway pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 43 Norway pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 44 Sweden pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 45 Sweden pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 46 Sweden pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 47 Asia Pacific pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 50 Asia Pacific pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 51 China pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 52 China pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 53 China pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 54 Japan pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 55 Japan pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 56 Japan pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 57 India pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 58 India pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 59 India pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 60 South Korea pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 61 South Korea pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 62 South Korea pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 63 Australia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 64 Australia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 65 Australia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 66 Thailand pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 67 Thailand pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 68 Thailand pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 69 Latin America pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 71 Latin America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 72 Latin America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 73 Brazil pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 74 Brazil pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 75 Brazil pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 76 Argentina pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 77 Argentina pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 78 Argentina pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 83 South Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 84 South Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 85 South Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 89 UAE pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 90 UAE pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 91 UAE pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 92 Kuwait pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 93 Kuwait pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 94 Kuwait pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 4 Global pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 5 Global pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 6 Global pharmaceutical transportation services Market, by Region, 2018 - 2030 (USD Million)
Table 7 North America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 8 North America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 9 North America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 10 U.S. pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 11 U.S. pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 12 U.S. pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 13 Canada pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 14 Canada pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 15 Canada pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 16 Mexico pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 17 Mexico pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 18 Mexico pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 19 Europe pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 21 Europe pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 22 Europe pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 23 Germany pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 24 Germany pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 25 Germany pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 26 UK pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 27 UK pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 28 UK pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 29 France pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 30 France pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 31 France pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 32 Italy pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 33 Italy pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 34 Italy pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 35 Spain pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 36 Spain pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 37 Spain pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 38 Denmark pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 39 Denmark pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 40 Denmark pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 41 Norway pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 42 Norway pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 43 Norway pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 44 Sweden pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 45 Sweden pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 46 Sweden pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 47 Asia Pacific pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 50 Asia Pacific pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 51 China pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 52 China pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 53 China pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 54 Japan pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 55 Japan pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 56 Japan pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 57 India pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 58 India pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 59 India pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 60 South Korea pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 61 South Korea pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 62 South Korea pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 63 Australia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 64 Australia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 65 Australia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 66 Thailand pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 67 Thailand pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 68 Thailand pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 69 Latin America pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 71 Latin America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 72 Latin America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 73 Brazil pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 74 Brazil pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 75 Brazil pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 76 Argentina pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 77 Argentina pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 78 Argentina pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 83 South Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 84 South Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 85 South Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 89 UAE pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 90 UAE pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 91 UAE pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
Table 92 Kuwait pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
Table 93 Kuwait pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
Table 94 Kuwait pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Pharmaceutical Transportation Services Market Segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot 1
Fig. 14 Segment snapshot 2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL by SWOT analysis
Fig. 19 Pharmaceutical transportation services market: Type outlook key takeaways
Fig. 20 Pharmaceutical transportation services market: Type movement analysis
Fig. 21 Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Pharmaceutical Transportation Services Market: Services outlook key takeaways
Fig. 28 Pharmaceutical Transportation Services Market: Services movement analysis
Fig. 29 Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Regional marketplace outlook, 2024 & 2030 (USD Million)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 North America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 U.S. pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 Canada pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Mexico pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Europe pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Germany pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 France pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Italy pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Spain pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Denmark pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Norway pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Sweden pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Japan pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 China pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 India pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Australia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 South Korea pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Thailand pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Latin America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Brazil pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Argentina pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 MEA pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 South Africa pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Saudi Arabia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 UAE pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Kuwait regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Market participant categorization
Fig. 87 Precision medicine market share/assessment analysis, 2024
Fig. 88 Strategic framework
Fig. 1 Pharmaceutical Transportation Services Market Segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot 1
Fig. 14 Segment snapshot 2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL by SWOT analysis
Fig. 19 Pharmaceutical transportation services market: Type outlook key takeaways
Fig. 20 Pharmaceutical transportation services market: Type movement analysis
Fig. 21 Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Pharmaceutical Transportation Services Market: Services outlook key takeaways
Fig. 28 Pharmaceutical Transportation Services Market: Services movement analysis
Fig. 29 Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Regional marketplace outlook, 2024 & 2030 (USD Million)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 North America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 U.S. pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Key country dynamics
Fig. 37 Canada pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Key country dynamics
Fig. 39 Mexico pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 Europe pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Germany pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Key country dynamics
Fig. 47 France pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 Italy pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Spain pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Denmark pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Norway pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Sweden pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Japan pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 China pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 India pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Australia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 South Korea pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Thailand pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Latin America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Brazil pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Argentina pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 MEA pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 South Africa pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Saudi Arabia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 UAE pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Kuwait regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Market participant categorization
Fig. 87 Precision medicine market share/assessment analysis, 2024
Fig. 88 Strategic framework
